SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is experiencing extreme volatility driven by a massive market sell-off in South Korea, fueled by concerns over leveraged ETF unwinding and institutional rebalancing. Community members are actively debating the sustainability of the memory sector boom, with many viewing the sharp price swings as an opportunity for tactical accumulation ahead of major upcoming events like the SK Hynix IPO.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing heightened community activity following institutional ownership filings and an annual meeting where management emphasized production scaling to meet AI infrastructure demand. While some investors remain cautious about execution timelines and recent price volatility, others are focused on the company's shift toward high-volume manufacturing and its potential to alleviate industry-wide data center bottlenecks.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is seeing increased social media engagement as investors weigh the potential of its anode-free solid-state battery technology against ongoing concerns about commercialization timelines and lack of revenue. Community discussion is heavily focused on upcoming earnings and the critical need for manufacturing progress on the Eagle Line to validate the company's long-term value.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

The VanEck Semiconductor ETF is experiencing high volatility as investors rotate capital amid concerns regarding elevated sector valuations and shifting AI demand outlooks. The community is actively debating the sustainability of AI capital expenditures, with significant attention on upcoming earnings reports and recent global market signals to determine if this marks a healthy consolidation or a deeper trend reversal.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Penguin Solutions is rallying on strong demand for AI infrastructure and memory systems, fueled by its role as an NVIDIA AI Factory partner and record quarterly sales. While bulls celebrate the company's position in the AI hardware supply chain, the stock is also seeing high volatility as traders debate whether it is a long-term growth play or an overextended trade prone to a pullback.

Roundhill ETF Trust - Roundhill Memory ETF

The DRAM ETF is attracting intense attention as the memory sector recovers, fueled by strong institutional demand for the upcoming SK Hynix Nasdaq IPO and positive momentum from South Korean chipmakers. Investors are actively debating whether this pullback represents a healthy reset in the AI infrastructure cycle or a shift in the long-term memory supply narrative.

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending as investors remain focused on commercial execution and the potential for long-term profitability, despite ongoing volatility and concerns regarding management's capital allocation. The community is actively debating the impact of the final legal resolution on product reimbursement, while weighing whether current price action represents a buying opportunity or a signal of deeper institutional skepticism.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is surging after announcing a fivefold expansion of its partnership with Brookfield, with financing commitments scaling from $5 billion to $25 billion to support the power needs of AI data centers. Investors are actively discussing this move as a major validation of the company's fuel-cell technology in addressing critical AI infrastructure power bottlenecks, despite ongoing debates regarding its valuation and supply chain dependencies.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines is trending as investors digest unprecedented Phase 3 data for daraxonrasib in pancreatic cancer, which demonstrated a significant survival benefit and reduction in death risk compared to standard chemotherapy. Community discussion remains intensely focused on the stock's potential as a major acquisition target, with active debates centered on whether the company should pursue an independent path to commercialization or accept a potential buyout from large pharmaceutical players.

TokenOS is the world’s most advanced AI-powered Web3 development platform, designed to turn natural language prompts into fully functional, production-ready blockchain applications. From simple tokens and memecoins to complex DeFi protocols, TokenOS automates the creation, deployment, and auditing of smart contracts and dApps with enterprise-grade reliability. By combining advanced language models with blockchain infrastructure, TokenOS removes the barriers of technical expertise, making Web3 development accessible to everyone. With instant deployment, built-in security best practices, and cross-chain support on the roadmap, TokenOS empowers entrepreneurs, developers, and creators to launch tokenized businesses and decentralized applications in seconds.

TokenOS AI

TokenOS AI is trending as investors rally around the project's v4 launch and a revenue-sharing model that distributes earnings from its decentralized GPU compute network to node runners and stakers. Community members are actively highlighting the high percentage of supply locked in long-term staking, which is driving intense discussion about potential supply scarcity and the token's long-term utility in the AI infrastructure sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLS REGAL Phase 3 &amp; SLS009 advancing — Two AML shots on goal — a lifeline for patients, hope for families, and upside for investors. 🚀 #SLS #Biotech

cb5000calls

Josh Greene

Pieter Dee

Louise

Roger Rabbit $5,56

YEHMINGZHU

Matt

Captain

Longnstrongdong

CannonPC

Chessdoc

Mohamad abou ardini

Stephen

StockTwits for iOS

SELLAS Life Sciences Group Inc

 REGAL Phase 3 & SLS009 advancing — Two AML shots on goal — a lifeline for patients, hope for families, and upside for investors. 🚀 